Complex II assembly drives metabolic adaptation to OXPHOS dysfunction
Science Advances · 2025
DOI: 10.1126/sciadv.adr6012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Roopasingam Kugapreethan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Oxidative Phosphorylation, Electron Transport Complex II, Adaptation, Physiological. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
During acute oxidative phosphorylation (OXPHOS) dysfunction, reversal of succinate dehydrogenase (complex II) maintains the redox state of the Coenzyme Q (Q)–pool by using fumarate as terminal electron acceptor in certain tissues and cell lines. We identified the action of SDHAF2 protein, a complex II assembly factor, as critical for metabolic adaptation during complex III dysfunction in HEK293T cells. SDHAF2 loss during complex III inhibition led to a net reductive TCA cycle from loss of succinate oxidation, loss of SDHA active site–derived reactive oxygen species (ROS) signaling, insufficient glycolytic adaptation, and a severe growth impairment. Glycolysis adapted cells, however, did not accumulate SDHAF2 upon Q-pool stress, exhibited a net reductive TCA cycle and mild growth phenotypes regardless of SDHAF2 presence. Thus, our study reveals how complex II assembly controls a balance between dynamics of TCA cycle directionality, protection from Q-pool stress, and an ability to use ROS-meditated signaling to overcome acute OXPHOS dysfunction in cells reliant on mitochondrial respiration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
- Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
- Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
- Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
- Melbourne Mass Spectrometry and Proteomics Facility (MMSPF), Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
- Victorian Clinical Genetics Services, Royal Children's Hospital, Parkville, VIC, Australia.
ORCID-Profile: Roopasingam Kugapreethan, Ann E Frazier, Tanavi Sharma, Michael G Leeming, Linden Muellner-Wong, Karena Last, David P De Souza, David R Thorburn, Malcolm J McConville, David A Stroud
Zitieren
APA
Kugapreethan, R., Elahee Doomun, S. N., Sacharz, J., Frazier, A. E., Sharma, T., Low, Y. C., Nie, S., Leeming, M. G., Muellner-Wong, L., Last, K., Stait, T., De Souza, D. P., Thorburn, D. R., McConville, M. J., & Stroud, D. A. (2025). Complex II assembly drives metabolic adaptation to OXPHOS dysfunction. Science Advances. https://doi.org/10.1126/sciadv.adr6012
Vancouver
Kugapreethan R, Elahee Doomun SN, Sacharz J, Frazier AE, Sharma T, Low YC, et al. Complex II assembly drives metabolic adaptation to OXPHOS dysfunction. Science Advances. 2025. doi:10.1126/sciadv.adr6012
BibTeX
@article{Kugapreethan2025,
author = {Kugapreethan, Roopasingam and Elahee Doomun, Sheik Nadeem and Sacharz, Joanna and Frazier, Ann E and Sharma, Tanavi and Low, Yau Chung and Nie, Shuai and Leeming, Michael G and Muellner-Wong, Linden and Last, Karena and Stait, Tegan and De Souza, David P and Thorburn, David R and McConville, Malcolm J and Stroud, David A},
title = {Complex II assembly drives metabolic adaptation to OXPHOS dysfunction},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr6012}
}
EUVIMED